The implications are significant: Repurposing an inexpensive, widely available drug Targeting the intersection of inflammasome activation, TP53 dysfunction, and neoplastic risk Potential relevance for disorders ranging from CAPS and histiocytosis to MDS and beyond We urgently need more translational work on this underappreciated molecule
thus, they are an attractive therapeutic option for patients with type 2 diabetes, especially those with existing cardiovascular disease or at high risk for those complications
These include reports on both lab work and clinical trials: But just counting dollars and studies doesnt quite capture the potential impact of GLP-1 drugs
Tesamorelin Blood Tests & Monitoring Tesamorelin is an approved GHRH analog in a specific clinical context and increases IGF-1
This is a reversible condition
Complete guide to injectable protocols for burns, scars, and skin injuries